Dr. Lal PathLabs Invests up to INR 30.3 Crores in Subsidiary PUPL
Dr. Lal PathLabs Ltd 路 Others (Uncategorized) 路 12 Oct 2026, 7:33 pm
Dr. Lal PathLabs Invests up to INR 30.3 Crores in Subsidiary PUPL Dr. Lal PathLabs has completed an additional cash equity investment not exceeding INR 30.3 Crores in its wholly owned subsidiary, PathLabs Unifiers Private Limited (PUPL), on 12th Oct'26. The capital infusion will fund PUPL's acquisition of the remaining 30% equity stake in CentraPath Labs Private Limited (CPL), making CPL a wholly owned subsidiary of PUPL. PUPL, operating in healthcare and diagnostic services, reported turnovers of INR 7.23 Crores in FY26, INR 7.10 Crores in FY25, and INR 7.28 Crores in FY24.
Original exchange filing (PDF)
More announcements from Dr. Lal PathLabs Ltd
- Attached 路 11 Nov 2026
- Attached 路 10 Nov 2026
- Attached 路 05 Nov 2026
- Attached 路 04 Nov 2026
- Attached 路 04 Nov 2026
- Attached 路 04 Nov 2026
- Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Ms Vasuta Agarwal as Additional Director designated as Non- Executive Independent Director of the company w.e.f. November 04, 2026. 路 04 Nov 2026
- Attached 路 04 Nov 2026
